“`html
Midi Health Secures $100M Series D Funding to Expand WomenS Healthcare Platform
Midi Health, a digital health company focused on women’s health, has raised $100 million in Series D funding, bringing its valuation to over $1 billion. This milestone signifies growing investment in a historically underfunded sector adn positions Midi Health for notable expansion beyond its initial focus on menopause care. The funding will fuel the company’s transition into a thorough “lifelong care” platform addressing cardiology, obesity, autoimmune conditions, and longevity for women. [https://www.midihealth.com/press-release-series-d](https://www.midihealth.com/press-release-series-d)
From Menopause to Lifelong Care: A Platform Approach
Founded initially to address the challenges of menopause, Midi Health is evolving into a broader women’s health platform. this strategic shift is driven by both the significant market chance and the potential for improved patient outcomes.Approximately two million U.S. women enter menopause annually, and the economic burden of untreated symptoms is estimated at $25 billion per year. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6227549/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6227549/) though, women’s health needs extend far beyond menopause, encompassing chronic conditions like heart disease and obesity, which disproportionately affect women. By providing continuous care throughout a woman’s life, Midi Health aims to build lasting patient relationships and improve long-term health management.
AI-Powered Care at Scale
Midi Health currently serves over 25,000 patients weekly and provides access to care for 45 million women through insurance coverage. [https://www.midihealth.com/press-release-series-d](https://www.midihealth.com/press-release-series-d) To manage this scale and maintain quality of care, the company is heavily investing in artificial intelligence (AI). Midi’s proprietary AI engine is designed to:
- Personalize care Pathways: AI analyzes patient charts to tailor treatment plans before consultations with healthcare providers.
- Streamline Clinical Workflows: Automation of tasks like triage and documentation reduces administrative burden on clinicians, freeing up time for patient care.
- Advance Research and Improve Outcomes: Leveraging a large dataset of midlife women’s health details to identify trends, refine treatment protocols, and improve health outcomes.
Executive Leadership Expansion
To support its rapid growth, Midi Health has appointed Jason Wheeler as Chief Financial Officer (CFO). Wheeler brings extensive experience from leadership roles at Tesla and Google. [https://www.linkedin.com/in/jasonwheelercfo/](https://www.linkedin.com/in/jasonwheelercfo/) The company has also added Melissa Waters as Chief Marketing Officer (CMO),formerly of Meta and Lyft,and Matt Cook as Chief Commercial Officer (CCO). These strategic hires are intended to prepare the company for potential future initial public offering (IPO) plans.
Key Takeaways
- Significant Funding: The $100M Series D round validates the growing demand for specialized women’s health solutions.
- Platform Expansion: Midi Health is moving beyond menopause to address a wider range of women’s health needs.
- AI-Driven Efficiency: AI is crucial for scaling operations and delivering personalized care at a large volume.
- strong Leadership Team: New executive appointments signal preparation